Investing

JPMorgan says this new player in the GLP-1 market could rally 45%

This GLP-1 drug could emerge as the next big treatment and rival key competitors.

adminadmin
Sep 12, 2024 - 02:00
 0  9
JPMorgan says this new player in the GLP-1 market could rally 45%
This GLP-1 drug could emerge as the next big treatment and rival key competitors.
Read More

Tags:

Previous Article

A 'butterfly' options spread trade that pays off if there's an earnings-driven r...

Next Article

Here are Wednesday's biggest analyst calls: Nvidia, Apple, Spotify, Arm, Robinho...

admin
admin

Related Posts

Roth conversions are up in 2024 — but it's not always a 'slam dunk,' accountant says

Roth conversions are up in 2024 — but it's not always a...

admin May 29, 2024  0  7

Short squeezes driven by renewed meme enthusiasm about to violently reverse, says chart analyst

Short squeezes driven by renewed meme enthusiasm about ...

admin May 15, 2024  0  12

When to book holiday travel this fall: 'That window of low prices is brief,' economist says

When to book holiday travel this fall: 'That window of ...

admin Sep 15, 2024  0  6